JAGSNPHARM Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > jagsnpharm

Technical Analysis

Technical Strength: 2.7 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 33.4. According to RSI analysis, jagsnpharm is technically weak. 1.0 JAGSNPHARM RSI Chart
MACD (?) MACD: -1.54 and Signal Line: -1.6. According to MACD analysis, jagsnpharm is marginally strong. 7.0 JAGSNPHARM MACD Chart
Simple Moving Average (?) According to simple moving average analysis, jagsnpharm is in a strong downtrend. Major resistance levels are 30.4775, 34.601, 34.96625. 0.0 JAGSNPHARM Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, jagsnpharm is in a strong downtrend. Major resistance levels are 30.4667, 32.89768, 35.27533. 0.0 JAGSNPHARM Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.242. According to bollinger bands, jagsnpharm is technically weak. 3.0 JAGSNPHARM Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is below all levels. Resistance levels are 30.2706 and 31.25. Support level is 27.1. 2.5 JAGSNPHARM Fibonacci Retracement Chart
Average True Range (?) ATR: 1.85 NA JAGSNPHARM Average True Range Chart
Average Directional Index (?) ADX is 21.9 which means JAGSNPHARM is in a trading range and there is no trend. NA JAGSNPHARM Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
March 16, 2018
Open Price 29.25
High Price 29.3
Low Price 28.7
Close Price 28.85
Absolute Change -0.35
Percentage Change -1.2%
Weekly Change 0%
Monthly Change -12.6%
Yearly Change -24.5%
52-week high 50.85
52-week low 27.1
Corporate Actions
ExDate Purpose
September 21, 2017 AGM/DIV-RE 0.10 PER SH
September 21, 2016 AGM/DIV-RE 0.10 PER SHARE
September 25, 2014 AGM/DIV-RE 0.50 PER SHARE
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.954
Confidence in Beta2.15%
Market Capital Rs. 75.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. 1.24
TTM Price-to-Earnings (P/E) Ratio 23.3
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 16 March 2018: Deliverable Quantity:4.38e+03 NA JAGSNPHARM Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 16 March 2018: Daily Volatility:0.491 NA JAGSNPHARM Annualized Daily Volatility (Spot Price) Chart


December 13, 2017 Committee Meeting Updates Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding Outcome of Committee Meeting held on December 12, 2017.
December 12, 2017 Outcome of Board Meeting Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on December 12, 2017.Sir/Madam,
See all Announcements

Board Meetings

Date Meeting Date Purpose
February 02, 2018 February 09, 2018 Results inter-alia, to consider and approve the Unaudited Financial Results (Standalone) for the quarter ended December 31, 2017.
May 22, 2017 May 28, 2017 Results/Dividend Inter alia to consider and approve the Audited Financial Results of the Company for the year from April 1st, 2016 to March 31, 2017 and consider Dividend,
See all Board Meetings

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 28 Rs. 28.35 Rs. 28.6 Rs. 28.95 Rs. 29.2 Rs. 29.55 Rs. 29.8